Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now
Close

Seagen Inc (SGEN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Seagen's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Seagen historical data, for real-time data please try another search
228.74 0.00    0.00%
13/12 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 228.74 - 228.96
Seagen 228.74 0.00 0.00%

Seagen Inc Company Profile

 
Get an in-depth profile of Seagen Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

3256

Equity Type

ORD

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. As of December 14, 2023, Seagen Inc. operates as a subsidiary of Pfizer Inc.

Contact Information

Address 21823 30th Drive SE
Bothell, 98021
United States
Phone 425 527 4000
Fax -
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SGEN Comments

Write your thoughts about Seagen Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Muhammad dayala
Muhammad dayala Jun 05, 2023 7:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
its an arbitrage opportunity
Milk Hey
Milk Hey Jul 18, 2022 9:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what happened?
Azeem Haider
Azeem Haider Sep 20, 2021 2:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
azeem Malik
Hakan YILMAZ
Hakan YILMAZ Feb 12, 2021 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The European Commission (EC) has granted marketing authorization for Seagen's (NASDAQ:SGEN) Tukysa (tucatinib) in combination with trastuzumab and capecitabine for the treatment of adult patients with HER2-positive locally advanced or metastatic breast cancer who have received at least two prior anti-HER2 treatment regimens.
Prabhu PR
PrabhuJ Feb 05, 2021 7:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is the news?
Ludovic Raymond
Ludovic Raymond Feb 05, 2021 7:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Apprently they may be included in the S&P 500, and hence funds. Just like Tesla a few weeks back
Hakan YILMAZ
Hakan YILMAZ Feb 05, 2021 7:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ludovic Raymond  Did you hold a position?
Hakan YILMAZ
Hakan YILMAZ Feb 01, 2021 11:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
Charles Coolidge
Charles Coolidge Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Price drop is the result of the #1 Institutional holder (Baker Bros) selling the entire position.
Hakan YILMAZ
Hakan YILMAZ Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You say Baker Bros sold the entire position, 27.5%. this is not possible. not that much volume.
Charles Coolidge
Charles Coolidge Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Executing through a secondary offering. The company issued a press release on it.
Mike Cronin
Mike Cronin Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Charles Coolidge, prove it.
Mike Cronin
Mike Cronin Jan 06, 2021 12:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Charles Coolidge, prove it.
Hakan YILMAZ
Hakan YILMAZ Dec 17, 2020 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seagen (SGEN) Gets Positive CHMP Opinion for Breast Cancer Drug  December 14, 2020
Nick Neri
Nick Neri Nov 30, 2020 4:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
180+
Nick Neri
Nick Neri Nov 13, 2020 4:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy buy buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email